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Background: Septation of a single ventricle into 2 functioning ventricles can provide
an alternative to the Fontan operation. However, early experiences with septation
reported unacceptable morbidity and mortality. The present study selected only
those patients with large volume-overloaded hearts, 2 well-functioning atrioventric-
ular valves, and an absence of severe outlet obstruction. Early and intermediate
outcomes are evaluated.
Methods and Results: Between June 1990 and March 1999, 11 patients underwent
septation in 1 or 2 stages. Diagnoses of the patients included double-inlet left
ventricle in 9, double-inlet right ventricle in 1 patient, and indeterminate ventricle in
1 patient. Five had L-transposition and 3 had D-transposition of the great arteries. Six
had septation as 1 stage, 5 as planned 2-stage operations (2/5 completed). The
median age for septation in 1 stage was 2.1 years (range 4 months to 5.8 years); for
2 stages, the median age was 7.2 months (range 3 to 14 months). Median follow-up
time was 2.3 years. Eight of 11 patients survived (73%), with 2 early deaths and 1
late death. Seven of the 8 survivors have undergone complete septation (5 as single
stage, 2 as 2 stages). Complications included surgically induced complete atrioven-
tricular block in 1 patient and significant residual ventricular septal defects in
another. Qualitatively, left ventricular function by echocardiography is normal in all
patients, whereas right ventricular function is mildly decreased in 1 patient. All
patients are clinically well.
Conclusion: The septation procedure for single ventricle hearts may be a reasonable
alternative to the Fontan operation in selected patients.
The first successful ventricular septation was performed in 1956 byKirklin.1 However, early experience with this procedure resulted inunacceptable morbidity and mortality.1-4 Possible risk factors forpoor outcome included random selection of patients, the necessity ofa ventriculotomy for the surgical approach, and loose patch place-ment resulting in inflow or outflow obstruction.5,6 The Fontan operation
is currently considered to be the surgical procedure of choice for patients with single
ventricle heart disease. However, since septation could provide a 4-chambered heart
as opposed to the Fontan operation, recent advances in surgical techniques have
renewed our interest in septation for carefully selected patients. Patients chosen for
septation in this study included those with 2 well-developed and normally func-
tioning atrioventricular (AV) valves; a large, volume-overloaded ventricle to opti-
mize right and left ventricular size after septation; and an absence of severe
subaortic obstruction or ventricular hypertrophy.
The original approach to septation was to use a ventriculotomy to create a septum
with a single patch. Whereas septation in 1 stage has been performed for more than
40 years, the 2-stage approach was proposed in 1984 by Ebert.7 He used 2 separate
patches in the initial stage. One patch was placed in the apex between the papillary
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muscles and another sutured between the aortic and pulmo-
nary anuli, thus leaving open the center section of the
neoseptum. Because there was no pressure gradient across
the septum, the patches stiffened and healed to the endo-
cardium. Fewer sutures needed to be placed, thus limiting
the possible damage to the conduction system. Since pa-
tients are left with an unrestrictive ventricular septal defect
(VSD) after the first stage, a pulmonary artery band was
placed if one was not already in place. In the present study,
the Ebert 2-stage technique was used for the younger and
smaller patients.
Methods
Patients
Between June 1990 and March 1999, 11 patients underwent ven-
tricular septation by a single surgeon at 2 medical centers (Table
1). Eight patients underwent surgery at Columbia-Presbyterian
Medical Center, and 3 underwent surgery at the Cardiothoracic
Centre of Monaco. There were 8 boys and 3 girls. Six patients had
a 1-stage procedure; 5 had a 2-stage procedure. One additional
patient went to the operating room for a septation procedure, but
had a Fontan operation instead, because of previously unappreci-
ated straddling of the tricuspid valve chordal apparatus.
The ventricular morphology included a double-inlet left ven-
tricle (DILV) in 9 patients, double-inlet right ventricle (DIRV) in
1 patient, and indeterminate ventricle in 1 patient (Table 1). Of the
9 patients with DILV, 5 had L-transposition of the great arteries
(L-TGA), 3 had normally related great arteries (NRGA), and 1 had
D-transposition of the great arteries (D-TGA). The patients with
DIRV and an indeterminate ventricle both had D-TGA. Two of the
patients had mildly restrictive bulboventricular foramina, each
with pressure gradients of 10 mm Hg from the left ventricle to the
aorta as measured by cardiac catheterization. Additional anomalies
of cardiac anatomy included coarctation of the aorta in 3 patients,
pulmonary stenosis in 2, and mitral valve obstruction in 1. It is
important to note that none of the patients had contraindications to
the Fontan procedure.
The median age for patients undergoing a 1-stage procedure
was 2.1 years (range 4 months to 5.8 years); the median weight
was 11.3 kg (range 4.0-19.6 kg). For the 5 infants undergoing a
planned 2-stage repair, the median age at the first stage was 7.2
TABLE 1. Summary of clinical data for 11 patients undergoing septation
Patient
No. Diagnosis
Age at first
septation
procedure
(y)
Prior
procedures
One- or two-stage
procedure
Associated
procedures Complications Results
1 DILV, L-TGA 1.2 None Two (complete) PAB (first stage),
PAB removal
(second stage)
None Survived
2 DILV, NRGA, PS 2.5 None One Pulmonary
valvotomy
None Survived
3 DILV, NRGA 0.33 None One None None Survived
4 Indeterminate
ventricle, D-TGA
1.1 PAB, atrial
septectomy
 2
One ASO, PAB removal Influenza B
pneumonia
Died
5 DILV, L-TGA 1.7 PAB One PAB removal None Survived
6 DIRV, D-TGA 0.33 None Two (complete) Atrial septectomy,
PAB (first stage),
ASO, PAB
removal (second
stage)
Residual VSDs
after second
stage
Survived
7 DILV, NRGA 5.8 PAB One PAB removal None Survived
8 DILV, L-TGA, PS 0.83 None Two (awaiting
completion)
None None Survived
9 DILV, D-TGA, CoA,
submitral narrowing
0.25 None Two (died after
first stage)
ASO, CoA repair,
mitral
valvuloplasty, PAB
Low cardiac
output
Died
10 DILV, L-TGA, CoA 4.3 PAB, CoA repair One BVF enlargement,
PAB removal
Postop
hemorrhage,
Complete AVB
Survived
11 DILV, L-TGA, CoA 0.63 PAB, CoA
repair, PM
placement
Two (died after
first stage)
BVF enlargement,
PAB removal
Fungal sepsis Died
ASO, Arterial switch operation; AVB, atrioventricular block; BVF, bulboventricular foramen; CoA, coarctation of the aorta; DILV, double-inlet left ventricle;
DIRV, double-inlet right ventricle; D-TGA, D-transposition of the great arteries; L-TGA, L-transposition of the great arteries; NRGA, normally related great
arteries; PAB, pulmonary artery banding; PS, pulmonary stenosis; VSD, Ventricular septal defect.
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months (range 3-14 months) with a median weight of 6.3 kg (range
3.8-9.0 kg). Two patients have had septation completed by means
of the 2-stage approach. The ages at completion were 11.5 months
and 22 months; the patients weighed 6.2 and 10 kg at the time of
the second stage. Two of the 1-stage patients were relatively young
at the time of the operation, 1 being 4 months old and the other 1
year old. Another underwent a 2-stage approach at the relatively
late age of 15 months old. These 3 patients underwent surgery
early in our experience, before our management strategy was
further defined.
Five of the 11 patients underwent surgery before a septation
procedure, 4 of the 1-stage patients and 1 of the 2-stage patients.
These included pulmonary artery banding in all 5, coarctation
repair in 2 and pacemaker insertion for intermittent complete heart
block in 1 patient with {S,L,L} morphology. Additional proce-
dures at the time of septation were required in 7 of 11 patients
(Table 2). The operative times for the patients are summarized in
Table 3. These times reflect the septation component of the oper-
ation, as well as additional surgical repairs.
Surgical Techniques
The operations were performed by means of cardiopulmonary
bypass with moderate hypothermia in 7 patients and deep hypo-
thermia in 4. Myocardial protection was achieved through cardio-
plegia administered every 30 minutes of aortic crossclamp time.
The operation was done in either a 1- or 2-stage technique. The
first parts of both methods are identical. In all patients a transatrial
approach through the right-sided AV valve was used, providing
complete exposure for septation. In 1 patient, after bulboventricu-
lar outflow tract enlargement, the left ventricular outflow tract was
assessed for adequacy by inspection through the aortic valve. The
initial part of the operation involves full delineation of the papil-
lary systems to verify the feasibility of septation. Specifically, the
chordal apparatus of both AV valves is inspected to determine
their exact attachment to be certain they straddle neither the outlet
chamber nor the contralateral ventricle. If portions of the chordal
insertions attach to the same papillary muscle, they are assessed for
the possibility of splitting the muscle to allow the insertion of the
septal patch. The ventricle is then divided with a polytetrafluoro-
ethylene* (PTFE) patch that is fashioned to provide an exact fit
(Figure 1). Any laxity in the patch can lead to inflow and/or
outflow obstruction in the postoperative period.
The patch is first attached at the apex of the heart between the
papillary muscles. By means of a running suture, the suture line is
then brought up between the 2 AV valve anuli and then between
the outlet valves. The relationship among the papillary muscles,
the AV valve anuli, and the 2 outlet valves determines patch
placement. There is little discretion left to the surgeon in these
areas. However, anteriorly the patch can be manipulated to adjust
the relative volumes of the right and left ventricles. Here, the patch
is placed in such a way that the left ventricular volume is slightly
larger than the right. Full attachment of the patch completes the
procedure for the 1-stage technique.
The 2-stage procedure is begun in the same manner. Once the
patch is in place, an unrestrictive VSD is created. The creation of
the VSD allows for further ventricular growth in smaller infants. If
the pulmonary vascular bed is not already protected by a pulmo-
nary artery band or native pulmonary stenosis, a band is placed at
the first stage. The VSD is then closed during the final stage with
a second PTFE patch. The second stage is generally done 6 to 12
months after the first.
Results
Perioperative
Figure 2 summarizes the outcome for the 11 patients in the
series. Of the 6 patients who underwent septation as a
1-stage procedure, 5 are alive and well. There was 1 early
death in this group. Among the 5 patients who had a 2-stage
procedure, 2 have undergone completion. There was 1 early
and 1 late death in this group. One patient is awaiting the
final stage of completion.
The overall mortality in this series was 3 of 11 (27%), 2
deaths occurring early and 1 late. One of the 2 early deaths
occurred in a 13-month-old child with an indeterminate
ventricular morphology and D-TGA (patient 4, Table 1) who
previously had undergone balloon atrial septostomy, pul-
monary artery banding, and blade atrial septostomy. He died
5 days postoperatively of influenza B pneumonia. The sec-
ond early death (patient 9) occurred in a 3-month-old infant
who had no prior procedures. His anatomy included DILV,
D-TGA, mitral valve obstruction, and a coarctation. He had
the most extensive surgery in this series of patients, includ-
ing partial septation, arterial switch, mitral valvuloplasty,
* Gore-Tex patch; registered trademark of W. L. Gore & Associates, Inc,
Flagstaff, Ariz.
TABLE 2. Procedures performed concurrently with septa-
tion
No.
PA band removal 5
Arterial switch 3
PA band 3
BVF enlargement 2
Coarctation repair 1
Pulmonary valvotomy 1
Mitral valvuloplasty 1
Atrial septectomy 1
BVF, Bulboventricular foramen; PA, pulmonary artery.
TABLE 3. Operative times
Median (min) Range (min)
Bypass time
One stage 135 75-233
First of 2 stages 124 93-193
Second of 2 stages 154 97-210
Crossclamp time
One stage 84 69-150
First of 2 stages 90 45-130
Second of 2 stages 75 45-105
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coarctation repair, and pulmonary artery banding. He died
of low cardiac output and poor ventricular performance 5
hours after the operation. The late death in this series
(patient 11, Table 1) occurred in an infant with DILV and
L-TGA who had previously undergone pulmonary artery
banding and coarctation repair and subsequently had a pace-
maker inserted for intermittent complete heart block. He had
a prolonged postoperative course after partial septation and
bulboventricular foramen enlargement. His recovery was
complicated by fungal sepsis, and he was discharged from
the hospital 2.5 months later. He died of complications of
fungal sepsis 5 months after the operation.
For the surviving patients, the median intensive care unit
stay was 6 days with a range of 2 to 165 days. The median
hospital stay was 16 days with a range of 10 to 194 days.
The outlying patient who was hospitalized for 194 days
(patient 6) was the only patient in the series with a DIRV
who required 2 surgical attempts at closure of residual
VSDs. The VSDs were ultimately closed with a clamshell
device.
Among the 8 survivors, 6 were in sinus rhythm after
septation. Patient 10 had complete heart block in the peri-
operative period. His operation included a 1-stage septation,
pulmonary artery band removal, and enlargement of the
bulboventricular foramen. He had a pacemaker placed 8
days after the opertion. In patient 4, heart block developed
7.5 months after the first stage of septation but before the
second stage.
Follow-up
The median follow-up time was 2.3 years with a range of 2
months to 8 years. All of the 8 survivors are asymptomatic;
6 of the 8 are receiving no cardiac medications. The 2
patients who continue to receive medications include patient
6 with a DIRV, and patient 10, whose operation was the
most recent.
Six patients have remained in sinus rhythm throughout
their clinical course. Patients 10 and 1 remain in heart block.
Ventricular function was assessed by 2-dimensional echo-
cardiography for qualitative evaluation of free wall motion
and thickening. All patients have good neo-left ventricular
function; patient 6, the 1 patient with a septated DIRV, has
mildly diminished neo-right ventricular function. No patient
has more that mild AV valve regurgitation by echocardiog-
raphy. The 7 fully septated patients have tiny, restrictive
patch margin leaks seen by color Doppler ultrasonography
only. Two patients have mild pulmonary stenosis, with
maximum Doppler instantaneous gradients of 20 mm Hg in
both. One of these 2 also has mild branch pulmonary artery
stenosis, with gradients of 20 mm Hg to the right and 25 mm
Hg to the left. No patient has left ventricular outflow tract
obstruction.
Discussion
Most centers use the Fontan operation as the sole surgical
option for single ventricles. Given the widely known late
complications associated with the Fontan procedure, we
hypothesized that in some patients the ventricular septation
procedure could provide a reasonable alternative, resulting
in biventricular physiology.
Septation of the single ventricle became a surgical option
after the first reported success by Kirklin1 in 1956. Although
Edie and associates8 reported early success with septation,
surgical mortality in most early series ranged from 36% to
47%.2,3,9 Since that time few reports have demonstrated
significant improvement in outcome. The major early draw-
backs to septation were the need for a ventriculotomy, loose
noncontractile patches that resulted in outflow obstruction,
surgically induced heart block, and paradoxical patch mo-
tion. In response, Doty, Schieken, and Lauer10 described a
transatrial approach in 1979, eliminating the need for a
ventriculotomy. Later, Ebert7 recommended a 2-stage ap-
proach in 1984. This technique limited the incidence of
surgically induced heart block, allowed tighter patch place-
Figure 1. The ventricle is divided with a fenestrated PTFE patch
first attached at the apex, between the papillary muscles. It is
then attached between the 2 AV valve anuli, then between the
outlet valves.
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ment to eliminate outflow obstruction, and permitted earlier
definitive surgery in young infants. Finally, the problem of
a noncontractile prosthetic septum compromising left ven-
tricular pump function necessitating greater end-diastolic
volume was addressed by asymmetric placement of the
neoseptum so that the left ventricle was slightly larger than
the right ventricle.11 With these surgical innovations and
increased experience with septation, one center has reported
recent success with septation.12
To improve outcomes in the present series still further,
we sought to add to the aforementioned refinements in
patient selection. McGoon and colleagues1 reported poor
outcome to be associated with abnormal AV valve function
and McKay and coworkers3 described small ventricular size
and bulboventricular foramen outlet obstruction as incre-
mental risk factors for hospital death. Nagashima and col-
leagues13 related ventricular hypertrophy to be a surgical
risk factor. Thus, based on the experience discussed in these
early reports, patients selected for septation in this series
included only those with 2 well-developed and normally
functioning AV valves; a large, volume-overloaded ventri-
cle; and an absence of severe subaortic obstruction and
ventricular hypertrophy.
The overall mortality for patients in this series was 27%
(3/11), which although superior to the previous septation
series, is still worse than that of comparable patients under-
going Fontan palliation. This may indicate that patient se-
lection needs to be limited even further, as the patients who
died generally required more extensive operations (eg, ar-
terial switch operation in 2 patients) than those who sur-
vived. The need for greater selectivity was also suggested
by the need for multiple reinterventions in the 1 patient in
this series with a morphologically right ventricle to close
residual VSDs.
Placing an artificial septum in a small child raises the
question of growth. Performing the first of a 2-stage septa-
tion early in life should result in a favorable patch-to-
myocardial mass relationship as the patient grows. The
absolute area of the septum that is patch material after
completed septation is relatively smaller in the older infant.
Long-term AV valve function in a heart whose septal length
is fixed, late cardiac rhythm, and ventricular function are
also unknown factors.
The surviving patients in this series have had good
clinical outcome and display qualitatively good ventricular
function. However, because of the irregular geometry of the
surgically created ventricles and lack of landmarks such as
regularly spaced papillary muscles, a noninvasive method
for formal assessment of ejection fraction and volume has
not been established. All patients also have good AV valve
function and have not experienced rhythm disturbances
during early and intermediate follow-up. Despite extensive
surgery in the region of the conduction system, only 1
patient had perioperative heart block, although late heart
block developed in 1 patient and another had a pacemaker
placed before septation. Longer follow-up, including formal
exercise testing and rhythm monitoring, will be needed to
determine whether this group will demonstrate superior
long-term outcomes compared with patients undergoing
conventional Fontan operations, as would be expected with
biventricular physiology.
Our results demonstrate that with careful patient selec-
tion, ventricular septation in patients with a single ventricle
heart can be accomplished with good results. On the basis of
Figure 2. Summary of surgical outcomes.
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our experience, certain features appear to lay the founda-
tions for better outcome: a morphologically left ventricle, 2
well-developed and normally functioning AV valves, a
large, volume-overloaded ventricle, and an absence of se-
vere subaortic obstruction and ventricular hypertrophy.
Complex procedures such as arterial switch operations dur-
ing the same operation should be avoided. It is likely that
criteria for septation may be further modified and expanded
in the future, as experience and new surgical techniques
evolve.
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